AstraZeneca Pharma fixes floor price for delisting at Rs 854.1

Image
Press Trust of India New Delhi
Last Updated : Apr 11 2014 | 9:13 PM IST
AstraZeneca Pharma has fixed the floor price at Rs 854.1 apiece for delisting its shares from stock exchanges.
Astrazeneca Pharmaceuticals AB, Sweden, holds 75 per cent stake in AstraZeneca Pharma India.
Astrazeneca Pharmaceuticals AB, the promoter of the company has informed that the "floor price in relation to the delisting proposal has been fixed at Rs 854.1 per equity share," the company said in a filing to the BSE.
AstraZeneca said that increase in promoter's ownership in the company will provide with greater operational flexibility to support the business.
Last month, AstraZeneca Pharma had received by email a letter from the promoter proposing to make a voluntary delisting offer to the public shareholders from stock exchanges.
The company on March 18 had annouced that its board approved delisting of the company's shares from bourses.
Shares of the company today closed at Rs 1,092.80 a share on the BSE.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 11 2014 | 9:13 PM IST

Next Story